Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06684418

Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer

Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer: A Multicenter, Prospective, Observational Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
6,000 (estimated)
Sponsor
Fudan University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This nationwide, multicenter observational study aims to develop and validate a multimodal artificial intelligence (AI) model for detecting occult lymph node metastasis in early-stage non-small cell lung cancer (NSCLC) patients. Despite advances in lymph node staging, 12.9%-39.3% of occult nodal metastasis cases remain undetected preoperatively, affecting treatment decisions. This study will use deep learning to extract imaging features of occult metastasis and combine them with clinical data to build an AI model for risk prediction. This study will provide insights into the feasibility of AI-driven detection of occult metastasis, supporting clinical decision-making and potentially revealing underlying biological mechanisms of lymph node metastasis in NSCLC.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTchest enhanced CTThis is an observational study and patients will receive routine clinical treatment according to the corresponding guidelines. We will collect the enrolled patient's chest enhanced CT and clinicopathological parameters.

Timeline

Start date
2024-12-01
Primary completion
2025-12-01
Completion
2026-06-30
First posted
2024-11-12
Last updated
2025-01-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06684418. Inclusion in this directory is not an endorsement.